Steven V O'Neil

Title: Innovations of Steven V O'Neil

Introduction

Steven V O'Neil is a notable inventor based in Newtown, PA, who has made significant contributions to the field of pharmaceuticals. He holds three patents, showcasing his expertise and innovative spirit in developing new medical solutions.

Latest Patents

His latest patents focus on heterocyclic sodium/proton exchange inhibitors. These compounds are designed to serve as sodium/proton exchange (NHE) inhibitors, which have a specific structure where n ranges from 1 to 5. The compounds include various functional groups, such as H, halo, alkenyl, alkynyl, alkoxy, alkyl, aryl, or heteroaryl. They are particularly useful as antianginal and cardioprotective agents. Additionally, O'Neil has developed methods for preventing or treating conditions such as angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia using these heterocyclic derivatives.

Career Highlights

Steven O'Neil is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has allowed him to focus on innovative drug development and contribute to advancements in medical treatments.

Collaborations

Throughout his career, O'Neil has collaborated with esteemed colleagues, including Saleem Ahmad and Shung C Wu. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Steven V O'Neil's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to impact the medical community positively.